
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : L-Carnosine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Monash Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Carnosine for Peripheral Vascular Disease
Details : Carnosine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Peripheral Arterial Disease.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
February 18, 2019
Lead Product(s) : L-Carnosine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Monash Health
Deal Size : Inapplicable
Deal Type : Inapplicable
